IFF’s Focus On Health And Environment Set To Drive Stock Momentum, Says Analyst
Oppenheimer initiates coverage on IFF at Outperform rating with $116 price target. Analyst sees potential for shareholder base shift and ongoing growth. Estimated EPS of $3.94 in FY24, $4.28 in FY25, and $4.61 in FY26. Investors can gain exposure through MVAL and IVEG.
